These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24399573)

  • 1. Correlates and Economic and Clinical Outcomes of an Adult IV to PO Antimicrobial Conversion Program at an Academic Medical Center in Midwest United States.
    Sallach-Ruma R; Nieman J; Sankaranarayanan J; Reardon T
    J Pharm Pract; 2015 Jun; 28(3):238-48. PubMed ID: 24399573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates and economic outcomes of proton pump inhibitor use by routes in intensive care unit patients.
    Sankaranarayanan J; Reardon T; Olsen KM
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):741-9. PubMed ID: 25059290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacist-initiated program of intravenous to oral antibiotic conversion.
    Przybylski KG; Rybak MJ; Martin PR; Weingarten CM; Zaran FK; Stevenson JG; Levine DP
    Pharmacotherapy; 1997; 17(2):271-6. PubMed ID: 9085318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
    McKinnon PS; Sorensen SV; Liu LZ; Itani KM
    Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of a pharmacist-managed dosage form conversion service on ciprofloxacin usage at a major Canadian teaching hospital: a pre- and post-intervention study.
    Ho BP; Lau TT; Balen RM; Naumann TL; Jewesson PJ
    BMC Health Serv Res; 2005 Jun; 5():48. PubMed ID: 15987523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous-to-oral stepdown program: four years of experience in a large teaching hospital.
    Frighetto L; Nickoloff D; Martinusen SM; Mamdani FS; Jewesson PJ
    Ann Pharmacother; 1992 Nov; 26(11):1447-51. PubMed ID: 1477451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study.
    Dunn K; O'Reilly A; Silke B; Rogers T; Bergin C
    Int J Clin Pharm; 2011 Apr; 33(2):208-14. PubMed ID: 21744190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of pharmacist-managed early switch from intravenous to oral therapy using electronic identification at a tertiary academic hospital.
    Babonji A; Darwesh B; Al-Alwai M
    Saudi Pharm J; 2021 Apr; 29(4):324-336. PubMed ID: 33994827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budget impact analysis of conversion from intravenous to oral medication when clinically eligible for oral intake.
    Lau BD; Pinto BL; Thiemann DR; Lehmann CU
    Clin Ther; 2011 Nov; 33(11):1792-6. PubMed ID: 22001356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program.
    Standiford HC; Chan S; Tripoli M; Weekes E; Forrest GN
    Infect Control Hosp Epidemiol; 2012 Apr; 33(4):338-45. PubMed ID: 22418628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Show me the money: long-term financial impact of an antimicrobial stewardship program.
    Beardsley JR; Williamson JC; Johnson JW; Luther VP; Wrenn RH; Ohl CC
    Infect Control Hosp Epidemiol; 2012 Apr; 33(4):398-400. PubMed ID: 22418636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
    Bhavan KP; Brown LS; Haley RW
    PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of linezolid and vancomycin in the treatment of surgical site infections.
    Patanwala AE; Erstad BL; Nix DE
    Curr Med Res Opin; 2007 Jan; 23(1):185-93. PubMed ID: 17257479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for reduction in the duration of intravenous drug use: Interest of drug tracers as quality indicators to improve intravenous to oral switch.
    Corny J; Perreau S; Thivilliers AP; Leplay C; Chevalier D; Beaussier H; Bézie Y
    J Eval Clin Pract; 2017 Aug; 23(4):848-852. PubMed ID: 28271587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an intravenous-to-oral route conversion program for antimicrobial therapy at a Canadian tertiary care health facility.
    Zamin MT; Pitre MM; Conly JM
    Ann Pharmacother; 1997 May; 31(5):564-70. PubMed ID: 9161649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoeconomic considerations associated with the use of intravenous-to-oral moxifloxacin for community-acquired pneumonia.
    Davis SL; Delgado G; McKinnon PS
    Clin Infect Dis; 2005 Jul; 41 Suppl 2():S136-43. PubMed ID: 15942880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct medical costs associated with using vancomycin in methicillin-resistant Staphylococcus aureus infections: an economic model.
    Shah NP; Reddy P; Paladino JA; McKinnon PS; Klepser ME; Pashos CL
    Curr Med Res Opin; 2004 Jun; 20(6):779-90. PubMed ID: 15200734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Big Clinical Data" Analysis of Intravenous to Oral Conversions of Non-Antimicrobials.
    Beeler PE; Bates DW; Blaser J
    Stud Health Technol Inform; 2017; 245():1251. PubMed ID: 29295336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage.
    Spiegel BM; Dulai GS; Lim BS; Mann N; Kanwal F; Gralnek IM
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):988-997. PubMed ID: 16844422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveling Up: Evaluation of IV v. PO Linezolid Utilization and Cost after an Antimicrobial Stewardship Program Revision of IV to PO Conversion Criteria within a Healthcare System.
    Jaggar J; Cleveland KO; Twilla JD; Patterson S; Hobbs ALV
    Pharmacy (Basel); 2023 Apr; 11(2):. PubMed ID: 37104076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.